antibodies, the authors immunostained sections of formalin fixed, paraffin embedded tissues from 289 Stage I NSCLCs. The Kaplan-Meier survival method, the log Department of Pathology, Baylor College of rank test, and Fisher's exact test were used for statistical analysis. Medicine and the Methodist
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma
โ Scribed by Martin Kunkel; Torsten E. Reichert; Peter Benz; Hans-Anton Lehr; Jong-Hyeon Jeong; Samuel Wieand; Peter Bartenstein; Wilfried Wagner; Theresa L. Whiteside
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 842 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
BACKGROUND
The overexpression of glucose transporters, especially of Glutโ1, is a common characteristic of human malignancies, including head and neck carcinoma. Recently, the assessment of glucose metabolism in the tumor with [^18^F]โ2โfluoroโ2 deoxyโDโglucose (FDG) and positron emission tomography (FDGโPET) has been used to identify particularly aggressive tumors. The authors tested the hypothesis that both glucose transport and its metabolism play a key role in the progression of oral squamous cell carcinoma (OSCC).
METHODS
Retrospective analysis of Glutโ1 expression was performed by immunohistology in 118 patients with OSCC, and a Glutโ1 labeling index (LI) was established for each. A separate group of 44 patients with primary OSCC was evaluated prospectively by FDGโPET prior to surgery. To link the expression of Glutโ1 with glucose metabolism, both FDGโPET and immunohistology were determined in a subgroup of 31 patients, and the results were correlated with overall survival.
RESULTS
The patients who had OSCC with a low LI for Glutโ1 survived significantly longer compared with patients who had OSCC with a high LI (138 months vs. 60 months; P = 0.0034). It was found that Glutโ1 expression was an independent marker of prognosis in patients with OSCC. In patients who were evaluated by FDGโPET, the standardized uptake value (SUV) below the median split value of 5.6 was predictive of a longer survival (P < 0.027), whereas an SUV > 5.6 was associated with an increased hazard of death. In combination, a high Glutโ1 level and a high SUV predicted shorter survival (P < 0.005) for patients with OSCC. Patients who achieved a complete response to preoperative radiation tended to have tumors with low glucose metabolism, as defined by both the Glutโ1 LI and the SUV.
CONCLUSIONS
Both glucose transport and glucose metabolism determine the glycolytic tumor phenotype, which is a significant negative biomarker of prognosis and overall survival in patients with OSCC. Cancer 2003;97:1015โ24. ยฉ 2003 American Cancer Society.
DOI 10.1002/cncr.11159
๐ SIMILAR VOLUMES
## Background: The objective of this study was to determine whether cyclooxygenase-2 (cox-2) overexpression was an indicator of prognosis in patients with international federation of gynecology and obstetrics (figo) stage iib uterine cervical carcinoma who underwent radiation and concurrent chemoth
## Abstract Human leukocyte antigen **(**HLA)โG inhibits functions of immune component cells and promotes malignant cells evading from antitumor immunity. We investigated the clinical relevance of HLAโG expression in esophageal squamous cell carcinoma (ESCC). In our study, HLAโG expression in 79 pr
## Abstract The enhancer of zeste homolog 2 (EZH2), a known repressor of gene transcription, has been reported to be associated with biological malignancy in several cancers. The potential oncogenic role of EZH2 and its clinical/prognostic significance, however, in esophageal squamous cell carcinom